On September 25, 2025, DarioHealth Corp. announced that it had completed an oversubscribed private placement of $17.5 million, raising fresh capital to support its commercial momentum. The placement was structured by converting preferred shares into common shares, thereby simplifying the company’s cap table and improving its balance‑sheet profile.
The board’s special committee, formed to evaluate strategic options, engaged Perella Weinberg Partners as a financial advisor. The committee’s mandate includes exploring a sale, merger, or continued standalone growth, and the new capital is intended to provide flexibility as the company pursues these possibilities.
The $17.5 million infusion strengthens DarioHealth’s liquidity, adding to its existing cash reserves and providing a buffer for ongoing operations and future growth initiatives. By optimizing its capital structure, the company positions itself to capitalize on unsolicited strategic inquiries and potentially unlock shareholder value through a transaction or expanded market reach.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.